IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pfizer walks away from AstraZeneca bid

9:49 AM MDT | May 26, 2014 | Natasha Alperowicz

Pfizer confirmed today that its “informal” offer to acquire AstraZeneca for £69.4 billion (117 billion) has lapsed and that it was consequently withdrawing the offer. This decision follows the expiry, at 5:00 pm BST, of a 28-day “put up or shut up” deadline under UK takeover rules by which Pfizer was required to make a firm offer to AstraZeneca shareholders. Pfizer made an “informal” but “final” offer of £55/share in cash and Pfizer shares on 19 May for AstraZeneca; that offer was rejected by the UK...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa